Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 5.30
+0.02 (0.38%)
Aug 26, 2026, 4:08 PM HKT
HKG:0512 Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 623.08 | 1,142 | 1,341 | 1,340 | 1,444 | 1,753 |
Short-Term Investments | - | 1,861 | 1,662 | 796.38 | 824.22 | 638.52 |
Trading Asset Securities | 602.5 | 924.17 | 1,800 | 1,135 | 1,070 | 1,113 |
Cash & Short-Term Investments | 1,226 | 3,927 | 4,803 | 3,271 | 3,338 | 3,504 |
Cash Growth | -47.65% | -18.23% | 46.84% | -2.02% | -4.74% | 33.93% |
Accounts Receivable | 5,446 | 2,506 | 1,572 | 2,068 | 1,947 | 1,810 |
Other Receivables | - | 367.85 | 280.34 | 256.18 | 259.44 | 225.82 |
Receivables | 5,446 | 2,873 | 1,852 | 2,324 | 2,207 | 2,149 |
Inventory | 1,479 | 1,484 | 1,371 | 1,389 | 1,340 | 1,117 |
Other Current Assets | 43.63 | 22.59 | - | 32.67 | 1.36 | 7.65 |
Total Current Assets | 8,195 | 8,308 | 8,026 | 7,016 | 6,887 | 6,779 |
Property, Plant & Equipment | 5,073 | 4,824 | 4,266 | 3,986 | 3,942 | 3,802 |
Long-Term Investments | 8,095 | 7,814 | 8,039 | 8,222 | 8,271 | 8,212 |
Goodwill | 1,802 | 1,677 | 1,300 | 588.62 | 644.05 | 596.75 |
Other Intangible Assets | 3,324 | 3,269 | 2,083 | 1,657 | 1,398 | 1,010 |
Long-Term Deferred Tax Assets | 110.51 | 70.63 | 33.46 | 25.11 | 24.59 | 24.61 |
Other Long-Term Assets | 1,512 | 1,203 | 1,245 | 1,021 | 1,204 | 633.26 |
Total Assets | 28,110 | 27,167 | 24,991 | 22,515 | 22,371 | 21,057 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4,003 | 1,818 | 1,217 | 1,330 | 872.86 | 734.5 |
Accrued Expenses | - | 2,118 | 1,711 | 1,499 | 1,615 | 2,137 |
Current Portion of Long-Term Debt | 1,669 | 2,831 | 3,130 | 2,320 | 3,245 | 2,127 |
Current Portion of Leases | 11.71 | 12.65 | 18.32 | 34.61 | 9.79 | 5.73 |
Current Income Taxes Payable | 220.71 | 195.63 | 241.27 | 332.06 | 369.74 | 354.55 |
Current Unearned Revenue | 200.41 | 323.93 | 242.72 | 198.17 | 318.82 | 202.11 |
Other Current Liabilities | 4.67 | 16.78 | 13.15 | 16.58 | 22.67 | 4.83 |
Total Current Liabilities | 6,109 | 7,317 | 6,573 | 5,731 | 6,455 | 5,566 |
Long-Term Debt | 3,331 | 1,841 | 1,256 | 990.03 | 1,162 | 1,510 |
Long-Term Leases | 42.04 | 40.28 | 40.6 | 61.61 | 60.08 | 13.31 |
Long-Term Unearned Revenue | 333.19 | 316.31 | 295.37 | 240.11 | 265.28 | 326.82 |
Long-Term Deferred Tax Liabilities | 366.62 | 367.27 | 300.35 | 221.63 | 220.15 | 197.85 |
Other Long-Term Liabilities | 569.07 | 105.8 | - | - | - | - |
Total Liabilities | 10,751 | 9,987 | 8,466 | 7,245 | 8,162 | 7,614 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 35.5 | 35.5 | 35.5 | 35.5 | 35.5 | 35.5 |
Additional Paid-In Capital | - | 6,644 | 6,644 | 6,644 | 6,644 | 6,644 |
Retained Earnings | - | 11,455 | 11,125 | 9,567 | 8,184 | 6,495 |
Treasury Stock | - | -268.5 | -268.5 | -268.5 | -187.49 | -143.5 |
Comprehensive Income & Other | 17,224 | -849.61 | -1,063 | -820.62 | -535.96 | 361.32 |
Total Common Equity | 17,259 | 17,017 | 16,473 | 15,158 | 14,140 | 13,393 |
Minority Interest | 99.92 | 162.65 | 52.13 | 112.8 | 68.32 | 50.23 |
Shareholders' Equity | 17,359 | 17,180 | 16,525 | 15,271 | 14,209 | 13,443 |
Total Liabilities & Equity | 28,110 | 27,167 | 24,991 | 22,515 | 22,371 | 21,057 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,053 | 4,725 | 4,445 | 3,407 | 4,478 | 3,656 |
Net Cash (Debt) | -3,828 | -797.39 | 357.94 | -135.89 | -1,139 | -151.9 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.09 | -0.23 | 0.10 | -0.04 | -0.32 | -0.04 |
Filing Date Shares Outstanding | 3,502 | 3,502 | 3,502 | 3,502 | 3,519 | 3,527 |
Total Common Shares Outstanding | 3,502 | 3,502 | 3,502 | 3,502 | 3,519 | 3,527 |
Working Capital | 2,086 | 990.82 | 1,452 | 1,285 | 432.32 | 1,212 |
Book Value Per Share | 4.93 | 4.86 | 4.70 | 4.33 | 4.02 | 3.80 |
Tangible Book Value | 12,134 | 12,071 | 13,091 | 12,912 | 12,098 | 11,786 |
Tangible Book Value Per Share | 3.46 | 3.45 | 3.74 | 3.69 | 3.44 | 3.34 |
Land | - | 1.66 | 1.6 | 1.65 | 1.7 | 1.84 |
Buildings | - | 3,007 | 2,573 | 2,476 | 2,337 | 2,357 |
Machinery | - | 3,240 | 2,935 | 2,785 | 2,581 | 2,440 |
Construction In Progress | - | 932.34 | 672.93 | 410.17 | 551.34 | 457.81 |